BUZZ-U.S. STOCKS ON THE MOVE-NeuroMetrix, Anavex, Pep Boys

Reuters Staff

3 Min Read

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks opened higher on Tuesday as crude prices edged up, recovering some of their Monday losses. The Dow Jones industrial average was up 0.91 percent at 17,687.28, the S&P 500 was up 0.76 percent at 2,072.08 and the Nasdaq Composite was up 0.67 percent at 5,074.741.

The medical technology company said it launched a nerve conduction test, used to evaluate systemic neuropathies such as diabetic peripheral neuropathy (DPN), in Mexico. DPN is long-term complication of diabetes.

** PEP BOYS-MANNY MOE & JACK, $18.78, +7.87 pct

The U.S. auto parts retailer said its board determined activist investor Carl Icahn's latest buyout offer was superior to the deal it accepted from Bridgestone Corp. Icahn raised his offer to value the company at about $1 billion.

The upscale grocer has agreed to pay $500,000 to resolve an investigation into whether the supermarket chain charged too much for some prepackaged foods at its New York City stores, a city agency announced on Monday.

** VALEANT PHARMACEUTICALS INTERNATIONAL INC, $102.33, +0.19 pct

The drug developer on Monday said a group of company executives will immediately take over for its chief executive officer until he returns from medical leave. (Compiled by Arunima Banerjee in Bengaluru; Editing by Maju Samuel)